Advertisement

Topics

Roche’s Genentech agrees to buy Jecure Therapeutics

04:23 EST 28 Nov 2018 | Pharmaceutical Business Review

Based in San Diego of California, Jecure Therapeutics is engaged in the discovery of therapeutics to treat non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure Therapeutics president and CEO

The post Roche’s Genentech agrees to buy Jecure Therapeutics appeared first on Pharmaceutical Business review.

Original Article: Roche’s Genentech agrees to buy Jecure Therapeutics

NEXT ARTICLE

More From BioPortfolio on "Roche’s Genentech agrees to buy Jecure Therapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...